nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acquired MET-DSTN Fusion Mediated Resistance to EGFR-TKIs in Lung Adenocarcinoma and Responded to Crizotinib Plus Gefitinib: A Case Report
|
Li, Yalun |
|
|
23 |
1 |
p. e83-e86 |
artikel |
2 |
A Reasonable Definition of Oligo-Recurrence in Non–Small-Cell Lung Cancer
|
Sonoda, Dai |
|
|
23 |
1 |
p. 82-90 |
artikel |
3 |
Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib
|
Tsui, David Chun Cheong |
|
|
23 |
1 |
p. e5-e8 |
artikel |
4 |
Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma
|
Handa, Yoshinori |
|
|
23 |
1 |
p. e9-e16.e1 |
artikel |
5 |
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non–Small Cell Lung Cancer
|
Page, Ray D. |
|
|
23 |
1 |
p. 72-81 |
artikel |
6 |
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial
|
Gadgeel, Shirish |
|
|
23 |
1 |
p. 21-33 |
artikel |
7 |
Current Strategies for Extensive Stage Small Cell Lung Cancer Beyond First-line Therapy
|
Hao, Zhonglin |
|
|
23 |
1 |
p. 14-20 |
artikel |
8 |
Editorial Board
|
|
|
|
23 |
1 |
p. A1 |
artikel |
9 |
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC
|
Hirsch, Fred R. |
|
|
23 |
1 |
p. 60-71 |
artikel |
10 |
Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer
|
Suda, Kenichi |
|
|
23 |
1 |
p. e60-e68 |
artikel |
11 |
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
|
Manglaviti, Sara |
|
|
23 |
1 |
p. e17-e28 |
artikel |
12 |
Neutrophil-to-lymphocyte ratio is correlated to driver gene mutations in surgically-resected non-small cell lung cancer and its post-operative evolution impacts outcomes
|
Seitlinger, Joseph |
|
|
23 |
1 |
p. e29-e42 |
artikel |
13 |
Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations
|
Hayashi, Hidetoshi |
|
|
23 |
1 |
p. e69-e82 |
artikel |
14 |
PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort
|
Jin, Yan |
|
|
23 |
1 |
p. 43-51 |
artikel |
15 |
Real-World Incidence of Pneumonitis in Patients Receiving Durvalumab
|
LeClair, Jessica N. |
|
|
23 |
1 |
p. 34-42 |
artikel |
16 |
Results of Second Round Lung Cancer Screening by Low-Dose CT scan - French Cohort Study (DEP-KP80)
|
Leleu, Olivier |
|
|
23 |
1 |
p. e54-e59 |
artikel |
17 |
Table of Contents
|
|
|
|
23 |
1 |
p. A2-A5 |
artikel |
18 |
The Combiome Hypothesis: Selecting Optimal Treatment for Cancer Patients
|
Hirsch, Fred R. |
|
|
23 |
1 |
p. 1-13 |
artikel |
19 |
The Common Thread: A Case of Synchronous Lung Cancers and a Germline CHEK2 Mutation
|
Carey, Edward T. |
|
|
23 |
1 |
p. e1-e4 |
artikel |
20 |
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer
|
Nagasaka, Misako |
|
|
23 |
1 |
p. 52-59 |
artikel |
21 |
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre
|
Schmid, Sabine |
|
|
23 |
1 |
p. e43-e53 |
artikel |